Pooled safety analyses from the teriflunomide clinical development program

被引：0
|
作者：
Leist, T. P. [1 ]
Freedman, M. S. [2 ,3 ]
Kappos, L. [4 ]
Olsson, T. P. [5 ]
Miller, A. E. [6 ]
Wolinsky, J. S. [7 ]
O'Connor, P. W. [8 ]
Benamor, M. [9 ]
Truffinet, P. [9 ]
Dukovic, D. [10 ]
Comi, G. [11 ]
机构：
[1] Thomas Jefferson Univ Hosp, Comprehens Multiple Sclerosis Ctr, Philadelphia, PA 19107 USA
[2] Univ Ottawa, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Univ Basel Hosp, CH-4031 Basel, Switzerland
[5] Karolinska Inst, Stockholm, Sweden
[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[7] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[8] Univ Toronto, Toronto, ON, Canada
[9] Genzyme, Chilly Mazarin, France
[10] Sanofi Rech, Bridgewater, NJ USA
[11] Uni Vita Salute San Raffaele, Milan, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P097
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [1] Pooled Safety Data from the Risdiplam Clinical Trial Development Program
    Servais, Laurent
    Baranello, Giovanni
    Bertini, Enrico
    Chiriboga, Claudia
    Darras, Basil T.
    Day, John W.
    Deconinck, Nicolas
    Fischer, Dirk
    Goemans, Nathalie
    Kirschner, Janbernd
    Klein, Andrea
    Masson, Riccardo
    Mazurkiewicz-Beldzinska, Maria
    Wang, Yi
    Bader-Weder, Silvia
    Gorni, Ksenija
    Jaber, Birgit
    McIver, Tammy
    Scalco, Renata S.
    Mercuri, Eugenio
    NEUROLOGY, 2021, 96 (15)
  • [2] Pooled Safety Data from the Risdiplam Clinical Trial Development Program
    Darras, Basil T.
    Chiriboga, Claudia A.
    Servais, Laurent
    Baranello, Giovanni
    Bertini, Enrico
    Day, John W.
    Deconinck, Nicolas
    Fischer, Dirk
    Goemans, Nathalie
    Kirschner, Janbernd
    Klein, Andrea
    Masson, Riccardo
    Mazurkiewicz-Beldzinska, Maria
    Wang, Yi
    Bader-Weder, Silvia
    Gorni, Ksenija
    Jaber, Birgit
    McIver, Tammy
    Scalco, Renata
    Mercuri, Eugenio
    NEUROLOGY, 2022, 98 (18)
  • [3] Pooled safety data from the risdiplam clinical trial development program
    Baranello, G.
    Servais, L.
    Bertini, E.
    Chiriboga, C.
    Darras, B.
    Day, J.
    Deconinck, N.
    Fischer, D.
    Goemans, N.
    Kirschner, J.
    Klein, A.
    Masson, R.
    Mazurkiewicz-Beldzinska, M.
    Wang, Y.
    Bader-Weder, S.
    Gorni, K.
    Jaber, B.
    McIver, T.
    Scalco, R.
    Mercuri, E.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S135 - S135
  • [4] Pooled safety data from the risdiplam clinical trial development program
    Servais, L.
    Baranello, G.
    Bertini, E.
    Chiriboga, C.
    Darras, B. T.
    Day, J. W.
    Deconinck, N.
    Fischer, D.
    Goemans, N.
    Kirschner, J.
    Klein, A.
    Masson, R.
    Mazurkiewicz-Beldzinska, M.
    Wang, Y.
    Bader-Weder, S.
    Gorni, K.
    Jaber, B.
    McIver, T.
    Scalco, R. S.
    Mercuri, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 397 - 398
  • [5] Pregnancy Outcomes from the Teriflunomide Clinical Development Program: Retrospective Analysis of the Teriflunomide Clinical Trial Database
    Henson, Lily Jung
    Stuve, Olaf
    Kieseier, Bernd
    Benamor, Myriam
    Benzerdjeb, Hadj
    NEUROLOGY, 2013, 80
  • [6] Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program
    Selmaj, Krzysztof W.
    Cohen, Jeffrey A.
    Comi, Giancarlo
    Bar-Or, Amit
    Arnold, Douglas L.
    Steinman, Lawrence
    Hartung, Hans Peter
    Montalban, Xavier
    Havrdova, Eva Kubala
    Cree, Bruce A. C.
    Minton, Neil
    Sheffield, James K.
    Ding, Ning
    Kappos, Ludwig
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51
  • [7] Long-Term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials
    Macdonell, R.
    Freedman, M. S.
    Ramio-Torrenta, L.
    Zaffaroni, M.
    De Seze, J.
    Ahn, S.
    Miller, A. E.
    Kallmann, B.
    Rog, D.
    Benamor, M.
    Truffinet, P.
    Chavin, J.
    Poole, E.
    Lebrun-Frenay, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 472 - 473
  • [8] Long-Term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials
    Freedman, Mark
    Inshasi, Jihad
    Ramio-Torrenta, Lluis
    Zaffaroni, Mauro
    de Seze, Jerome
    Ahn, Suk-won
    Macdonell, Richard
    Miller, Aaron
    Kallmann, Boris
    Rog, David
    Benamor, Myriam
    Truffinet, Philippe
    Chavin, Jeffrey
    Poole, Elizabeth
    Lebrun-Frenay, Christine
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 51 - 51
  • [9] Pooled Safety Data from the Risdiplam (RG7916) Clinical Trial Development Program
    Baranello, Giovanni
    Bertini, Enrico
    Chiriboga, Claudia
    Darras, Basil T.
    Day, John W.
    Deconinck, Nicolas
    Fischer, Dirk
    Goemans, Nathalie
    Kirschner, Janbernd
    Klein, Andrea
    Masson, Riccardo
    Mazurkiewicz-Beldzinska, Maria
    Servais, Laurent
    Wang, Yi
    Fuerst-Recktenwald, Sabine
    Gerber, Marianne
    Gorni, Ksenija
    Jaber, Birgit
    McIver, Tammy
    Scalco, Renata
    NEUROLOGY, 2020, 94 (15)
  • [10] Long-term efficacy and safety of teriflunomide: an analysis of pooled clinical trials
    Freedman, M. S.
    Ramio-Torrenta, L.
    Zaffaroni, M.
    De Seze, J.
    Ahn, S.
    Macdonell, R.
    Miller, A. E.
    Kallmann, B.
    Rog, D.
    Benamor, M.
    Truffinet, P.
    Chavin, J.
    Poole, E.
    Lebrun-Frenay, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 700 - 701
12345